News
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Long Island patients lost vision after taking weight loss drugs Ozempic and Wegovy, lawsuits contend
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.
The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
The company behind the weight loss sensation that transformed bodies and bank accounts across America just showed its own CEO ...
GLP-1 drugs like Wegovy and Ozempic are designed to treat type 2 diabetes, but are widely known for their effect on weight ...
Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results